Table 2 Comparative analysis of clinical baseline data between the c-Met low expression and high expression groups
Variable | c-Met expression [n (%)/mean (SD)] | t/X2 | p-value | |
|---|---|---|---|---|
c-Met low group (n = 34) | c-Met high group (n = 63) | |||
Age (years) | 57.35 (10.63) | 59.95 (9.61) | 1.224 | 0.224 |
Sex | ||||
 Female | 11 (32.35) | 12 (19.05) | 2.161 | 0.142 |
 Male | 23 (67.65) | 51 (80.95) | ||
Tumor diameter (cm) | 3.74 (1.82) | 4.11 (1.75) | 1.001 | 0.319 |
Tumor location | ||||
 Gastric body | 5 (14.71) | 9 (14.29) | 0.554 | 0.758 |
 Gastric antrum | 25 (73.53) | 43 (68.25) | ||
 Gastric fundus | 4 (11.76) | 11 (17.46) | ||
T stage | ||||
 T (1, 2) | 13 (38.24) | 13 (20.63) | 3.487 | 0.062 |
 T (3, 4) | 21 (61.76) | 50 (79.37) | ||
N stage | ||||
 N− | 11 (32.35) | 16 (25.40) | 0.532 | 0.466 |
 N+ | 23 (67.65) | 47 (74.60) | ||
M stage | ||||
 M− | 33 (97.06) | 51 (80.95) | 4.936 | 0.022 |
 M+ | 1 (2.94) | 12 (19.05) | ||
Clinicopathologic stage | ||||
 I–II | 22 (64.71) | 25 (39.68) | 5.536 | 0.019 |
 III–IV | 12 (35.29) | 38 (60.32) | ||
Differentiated degree | ||||
 Poor differentiation | 14 (41.18) | 40 (63.49) | 4.908 | 0.086 |
 Moderate differentiation | 17 (50.00) | 21 (33.33) | ||
 High differentiation | 3 (8.82) | 2 (3.17) | ||
HER2-IHC | ||||
 Missing | 1 (2.94) | 1 (1.59) |  |  |
 Negative | 31 (91.18) | 56 (88.89) | 0.365 | 0.546 |
 Positive | 2 (5.88) | 6 (9.52) | ||
H. pylori | ||||
 Missing | 6 (17.65) | 17 (26.98) |  |  |
 Negative | 14 (41.18) | 23 (36.51) | 0.001 | 1.000 |
 Positive | 14 (41.18) | 23 (36.51) | ||